[Hematological malignancy: management of anemia and leukopenia by primary care physicians]


Autoria(s): Burnand Jérôme; Waeber Gérard; Duchosal Michel A.
Data(s)

2009

Resumo

In hematological malignancies, the occurrence of anemia is very common and can have significant consequences on daily life. Treatment includes essentially red blood cell transfusions. The prescription of erythropoietic agents and/or iron is exceptionnal and often not registered in Switzerland. The onset of neutropenia is also frequently encountered and in some situations may require the prescription of myeloid growth factors. The purpose of this article is to focus on the current recommendations of these two issues for practitioners.

Identificador

http://serval.unil.ch/?id=serval:BIB_AC8587A11896

isbn:1660-9379 (Print)

pmid:19968027

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 5, no. 223, pp. 2147-2152, 2154-2155

Tipo

info:eu-repo/semantics/article

article